Genetic barrier to resistance for dolutegravir

AIDS reviews

Volumn 17, Issue 1, 2015, Pages 56-64

  Llibre, Josep M ^a   Pulido, Federico ^a   García, Federico ^a   García Deltoro, Miguel ^a   Blanco, José L ^a   Delgado, Rafael ^a  

^a Inst Invest Biosanitaria Ibs GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOLUTEGRAVIR; FUSED HETEROCYCLIC RINGS; INTEGRASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ANTIVIRAL RESISTANCE; DRUG EFFECTS; GENETICS; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MISSENSE MUTATION; PHASE 3 CLINICAL TRIAL (TOPIC); VIROLOGY;

CLINICAL TRIALS, PHASE III AS TOPIC; DRUG RESISTANCE, VIRAL; HETEROCYCLIC COMPOUNDS, 3-RING; HIV INFECTIONS; HIV INTEGRASE INHIBITORS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MUTATION, MISSENSE;

EID: 84929905730     PISSN: None     EISSN: 16986997     Source Type: Journal    
DOI: None     Document Type: Review

References (0)